These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19089675)

  • 1. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients.
    Del Popolo G; Panariello G; Del Corso F; De Scisciolo G; Lombardi G
    Neurol Sci; 2008 Dec; 29 Suppl 4():S352-5. PubMed ID: 19089675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and the neurogenic bladder.
    Rashid TM; Hollander JB
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):615-29. PubMed ID: 9894113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genitourinary changes in multiple sclerosis: the need for a urodynamic study].
    Martín C; Salinas J; Fernández-Durán A; Fernández-Gómez J; Jiménez N; Gangoiti L
    Rev Neurol; 2000 Apr 1-15; 30(7):643-8. PubMed ID: 10859743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic aspects of multiple sclerosis in urology: use of urodynamic methods of investigation.
    Becker F; Becker R; Valencic M; Broda M
    Int Urol Nephrol; 1982; 14(4):387-92. PubMed ID: 7182374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary management of the neurogenic bladder for multiple sclerosis patients.
    Stoffel JT
    Urol Clin North Am; 2010 Nov; 37(4):547-57. PubMed ID: 20955906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of neurogenic bladder in patients with multiple sclerosis.
    Phé V; Chartier-Kastler E; Panicker JN
    Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overactive bladder in multiple sclerosis.
    Fingerman JS; Finkelstein LH
    J Am Osteopath Assoc; 2000 Mar; 100(3 Suppl):S9-12. PubMed ID: 10763312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic bladder in the woman with multiple sclerosis.
    Summers JL
    J Urol; 1978 Nov; 120(5):555-6. PubMed ID: 712896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management of neurogenic bladder in patients with MS.
    Woodward S
    Br J Nurs; 2004 Apr 8-21; 13(7):362-70. PubMed ID: 15150474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
    McGuire EJ; Savastano JA
    J Urol; 1984 Oct; 132(4):713-5. PubMed ID: 6147423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and clinical evaluation of neurogenic bladder.
    Amarenco G; Sheikh Ismaël S; Chesnel C; Charlanes A; LE Breton F
    Eur J Phys Rehabil Med; 2017 Dec; 53(6):975-980. PubMed ID: 29072046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
    Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
    Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms.
    Tracey JM; Stoffel JT
    Investig Clin Urol; 2016 Nov; 57(6):377-383. PubMed ID: 27847911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder management in multiple sclerosis.
    Yang CC
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):673-86. PubMed ID: 24314685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of the urologic consequences of neurologic disease.
    Kotkin L; Milam DF
    Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of neuropathic bladder in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A
    Clin Ter; 2004 May; 155(5):183-6. PubMed ID: 15344566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Help for patients with multiple sclerosis: current diagnostic and treatment possibilities in neurogenic disorders of bladder emptying].
    Zwergel U; Wullich B; Jost WH; Zwergel T
    Dtsch Med Wochenschr; 1998 May; 123(22):707-12. PubMed ID: 9645188
    [No Abstract]   [Full Text] [Related]  

  • 19. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
    De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurogenic diseases of the bladder without urodynamic explanation].
    Schuyten H; Gentens P; Van Camp K
    Acta Urol Belg; 1979 Oct; 47(4):639-42. PubMed ID: 517346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.